NCT03430232View on ClinicalTrials.gov

First-In-Human PainCart Study for STR-324

PHASE1CompletedINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

November 7, 2018

Study Completion Date

November 7, 2018

Conditions

Pain

Interventions

DRUG

Placebo

Short infusion of the solution for intravenous administration, Sodium Chloride 0.9%

DRUG

STR-324 Dose Level 1

Short infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level 2

Short infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level 3

Short infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level 4

Short infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level 5

Short infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level 6

Short infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level 7

Short infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level 8

Short infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level A

Long infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level B

Long infusion of a solution for intravenous administration

DRUG

STR-324 Dose Level C

Long infusion of a solution for intravenous administration

DRUG

Placebo

Long infusion of the solution for intravenous administration, Sodium Chloride 0.9%

Trial Locations (1)

2333

CHDR, Leiden

All Listed Sponsors

lead

Stragen France

INDUSTRY

NCT03430232 - First-In-Human PainCart Study for STR-324 | Biotech Hunter | Biotech Hunter